Expanding the Pool in Orthotopic Heart Transplantation: The Use of Hepatitis C Positive Donor Hearts in Hepatitis C Negative Recipients
Latest Information Update: 13 Oct 2025
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 01 Oct 2025 Planned End Date changed from 31 May 2025 to 31 May 2026.
- 01 Oct 2025 Planned primary completion date changed from 31 May 2025 to 31 May 2026.
- 04 Feb 2025 Planned End Date changed from 31 Dec 2024 to 31 May 2025.